Biologic Therapeutics Market
Biologic Therapeutics Market Forecasts to 2030 - Global Analysis By Product (Gene Therapy, Cell Therapy, Vaccines, Antibody Therapeutics and Other Products), Type, Application and By Geography
|
Years Covered |
2021-2030 |
|
Estimated Year Value (2023) |
US $457.56 BN |
|
Projected Year Value (2030) |
US $968.08 BN |
|
CAGR (2023 - 2030) |
11.3% |
|
Regions Covered |
North America, Europe, Asia Pacific, South America, and Middle East & Africa |
|
Countries Covered |
US, Canada, Mexico, Germany, UK, Italy, France, Spain, Japan, China, India, Australia, New Zealand, South Korea, Rest of Asia Pacific, South America, Argentina, Brazil, Chile, Middle East & Africa, Saudi Arabia, UAE, Qatar, and South Africa |
|
Largest Market |
Asia Pacific |
|
Highest Growing Market |
Asia Pacific |
According to Stratistics MRC, the Global Biologic Therapeutics Market is accounted for $457.56 billion in 2023 and is expected to reach $968.08 billion by 2030 growing at a CAGR of 11.3% during the forecast period. The pharmaceutical industry sector that concentrates on the development, production, and marketing of therapeutic medicines generated from biological sources is referred to as the biologic therapeutics market. These complex chemicals are created using living organisms or their parts, such as proteins, antibodies, nucleic acids, or cells. They are also referred to as biologics or biological pharmaceuticals.
According to World Health Organization, vaccines are one of the most powerful and cost-effective ways to reduce the global burden of disease and are estimated to save 2–3 million lives every year.
Market Dynamics:
Driver:
Increasing prevalence of age-related and chronic diseases and expanding pipeline of biologics
The need for efficient treatment alternatives is being driven by the increased prevalence of chronic diseases like cancer, autoimmune conditions, and metabolic diseases. Biologic medicines provide customized, targeted treatments that can address the underlying causes of many disorders, spurring market expansion. Additionally, the development of biologic medicines has received significant funding from the pharmaceutical and biotechnology industries. Biologic medication development, including recombinant proteins, cell and gene therapies, and monoclonal antibodies, is boosting the market and spurring innovation.
Restraint:
High costs of development and production, manufacturing and supply chain management are quite complex
Complex procedures and high expenditures, such as those associated with research and development, clinical trials, and manufacturing facilities, are involved in the creation and production of biologic therapies. Particularly in healthcare systems with limited resources, these high costs may restrict the availability and affordability of biologic medications. However, due to their complicated nature, biologic pharmaceuticals need specialized production facilities and procedures. It can be difficult to ensure consistent quality, scaleability, and maintain a strong supply chain, which may have an impact on the accessibility and affordability of biologic treatments.
Opportunity:
Biotechnology and genetic engineering advancements and favorable regulatory landscape
The potential for creating innovative biological therapies has increased as a result of ongoing developments in biotechnology, genetic engineering, and recombinant DNA technology. These technological developments make it possible to produce biological medications that are more sophisticated and specifically targeted, expanding the number of available treatments. Additionally, regulatory organizations have established precise rules and accelerated paths for the approval of biologic therapies, including the European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA). These regulatory regimes offer a favorable environment for the creation, assessment, and marketing of biologic medicines.
Threat:
High standards of regulation and concerns about immunogenicity and safety
Despite the existence of favorable regulatory frameworks, the complex and stringent approval procedures for biologic therapies. Extensive preclinical and clinical trials that must be conducted by companies to prove safety, efficacy, and quality can take a long time and cost a lot of funds. However, patients' immune responses to biological therapies may be induced, raising concerns regarding their safety and immunogenicity. The effectiveness and safety of the treatment may be impacted by these immunological reactions, which can range in severity. For biological treatments to be used effectively, it is crucial to provide effective monitoring and management of these problems.
Covid-19 Impact:
The COVID-19 epidemic made the creation and distribution of efficient vaccinations essential. As a result, vaccine research and development significantly increased, utilizing biological platforms like mRNA and viral vector-based vaccines. The effective creation and application of COVID-19 vaccines highlighted the promise of biological treatments and emphasized the significance of the biotechnology sector in combating infectious diseases.
The blood products segment is expected to be the largest during the forecast period
Blood products segment commanded the largest share over the forecast period. Blood-derived products, including immunoglobulins, clotting factors, and plasma-derived proteins, which are used to treat a variety of blood illnesses and immunological deficiencies, are also considered to be part of biologic therapies. The use of these items is essential in the management of a number of blood diseases, immunological deficiencies, and other ailments.
The cell therapy segment is expected to have the highest CAGR during the forecast period
Cell therapy segment is estimated to witness lucrative growth over the projection period. Living cells are used in cell therapy to treat or cure diseases. It is a fast-developing area that seeks to replace, restore, or fix damaged or sick cells or tissues. Additionally, cell therapy has demonstrated potential in a number of therapeutic fields, including oncology, cardiovascular illness, neurodegenerative disorders, and autoimmune diseases.
Region with largest share:
Asia Pacific is expected to hold largest share over the forecast period as the biological therapies industry experiences substantial development and innovation, the Asia-Pacific region is emerging as a vibrant and quickly changing hub. This region is connected to numerous nations with distinctive healthcare systems, making it a complex yet attractive market. Additionally, the region's growing need for biological treatments is being driven by the prevalence of chronic diseases like cancer, diabetes, and autoimmune disorders.
Region with highest CAGR:
Asia Pacific is estimated to hold highest CAGR. The availability of biological therapies has expanded as a result of an expanding middle-class population and rising healthcare costs. This has further propelled the market's growth, along with government policies to encourage the construction of healthcare infrastructure. Additionally, the Asia-Pacific region is experiencing a boom in research and development activity, with both domestic and foreign pharmaceutical firms making significant investments in the development of biologic drugs. A thriving biotechnology ecosystem has resulted in an outcome that draws in talent and encourages innovation. Governments in the area are also making efforts to simplify approval procedures, improving the simplicity of market access for biopharmaceutical firms.
Key players in the market
Some of the key players in Biologic Therapeutics Market include AbbVie Inc, Amgen Inc., AstraZeneca Plc, Aurobindo Pharma Ltd., Baxter International Inc, Biocon Ltd., Celltrion Healthcare Co. Ltd., GlaxoSmithKline Plc, Merck and Co. Inc, Novartis AG, Pfizer Inc , Precision Biologics Inc and Samsung Electronics Co. Ltd.
Key Developments:
In May 2022, Precision BioLogic Inc., a leading developer of hemostasis diagnostic products, announceD the launch of its new CRYOcheck Chromogenic Factor IX assay in Canada, the European Union, Australia, and New Zealand following market authorization by Health Canada and respective in-country regulatory authorities. The announcement was made at the World Federation of Hemophilia Congress taking place in Montreal
Products Covered:
• Gene Therapy
• Cell Therapy
• Vaccines
• Antibody Therapeutics
• Other Products
Types Covered:
• Allergenic Extracts
• Blood Products
• Human Cells and Tissues
• Protein
• Xenotransplantation Products
• Other Types
Applications Covered:
• Autoimmune Diseases
• Infectious Diseases
• Cancer
• Other Applications
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Application Analysis
3.8 Emerging Markets
3.9 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Biologic Therapeutics Market, By Product
5.1 Introduction
5.2 Gene Therapy
5.3 Cell Therapy
5.4 Vaccines
5.5 Antibody Therapeutics
5.6 Other Products
6 Global Biologic Therapeutics Market, By Type
6.1 Introduction
6.2 Allergenic Extracts
6.3 Blood Products
6.4 Human Cells and Tissues
6.5 Protein
6.6 Xenotransplantation Products
6.7 Other Types
7 Global Biologic Therapeutics Market, By Application
7.1 Introduction
7.2 Autoimmune Diseases
7.3 Infectious Diseases
7.4 Cancer
7.5 Other Applications
8 Global Biologic Therapeutics Market, By Geography
8.1 Introduction
8.2 North America
8.2.1 US
8.2.2 Canada
8.2.3 Mexico
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 Italy
8.3.4 France
8.3.5 Spain
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 New Zealand
8.4.6 South Korea
8.4.7 Rest of Asia Pacific
8.5 South America
8.5.1 Argentina
8.5.2 Brazil
8.5.3 Chile
8.5.4 Rest of South America
8.6 Middle East & Africa
8.6.1 Saudi Arabia
8.6.2 UAE
8.6.3 Qatar
8.6.4 South Africa
8.6.5 Rest of Middle East & Africa
9 Key Developments
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies
10 Company Profiling
10.1 AbbVie Inc
10.2 Amgen Inc.
10.3 AstraZeneca Plc
10.4 Aurobindo Pharma Ltd.
10.5 Baxter International Inc
10.6 Biocon Ltd.
10.7 Celltrion Healthcare Co. Ltd.
10.8 GlaxoSmithKline Plc
10.9 Merck and Co. Inc
10.10 Novartis AG
10.11 Pfizer Inc
10.12 Precision Biologics Inc
10.13 Samsung Electronics Co. Ltd
List of Tables
1 Global Biologic Therapeutics Market Outlook, By Region (2021-2030) ($MN)
2 Global Biologic Therapeutics Market Outlook, By Product (2021-2030) ($MN)
3 Global Biologic Therapeutics Market Outlook, By Gene Therapy (2021-2030) ($MN)
4 Global Biologic Therapeutics Market Outlook, By Cell Therapy (2021-2030) ($MN)
5 Global Biologic Therapeutics Market Outlook, By Vaccines (2021-2030) ($MN)
6 Global Biologic Therapeutics Market Outlook, By Antibody Therapeutics (2021-2030) ($MN)
7 Global Biologic Therapeutics Market Outlook, By Other Products (2021-2030) ($MN)
8 Global Biologic Therapeutics Market Outlook, By Type (2021-2030) ($MN)
9 Global Biologic Therapeutics Market Outlook, By Allergenic Extracts (2021-2030) ($MN)
10 Global Biologic Therapeutics Market Outlook, By Blood Products (2021-2030) ($MN)
11 Global Biologic Therapeutics Market Outlook, By Human Cells and Tissues (2021-2030) ($MN)
12 Global Biologic Therapeutics Market Outlook, By Protein (2021-2030) ($MN)
13 Global Biologic Therapeutics Market Outlook, By Xenotransplantation Products (2021-2030) ($MN)
14 Global Biologic Therapeutics Market Outlook, By Other Types (2021-2030) ($MN)
15 Global Biologic Therapeutics Market Outlook, By Application (2021-2030) ($MN)
16 Global Biologic Therapeutics Market Outlook, By Autoimmune Diseases (2021-2030) ($MN)
17 Global Biologic Therapeutics Market Outlook, By Infectious Diseases (2021-2030) ($MN)
18 Global Biologic Therapeutics Market Outlook, By Cancer (2021-2030) ($MN)
19 Global Biologic Therapeutics Market Outlook, By Other Applications (2021-2030) ($MN)
20 North America Biologic Therapeutics Market Outlook, By Country (2021-2030) ($MN)
21 North America Biologic Therapeutics Market Outlook, By Product (2021-2030) ($MN)
22 North America Biologic Therapeutics Market Outlook, By Gene Therapy (2021-2030) ($MN)
23 North America Biologic Therapeutics Market Outlook, By Cell Therapy (2021-2030) ($MN)
24 North America Biologic Therapeutics Market Outlook, By Vaccines (2021-2030) ($MN)
25 North America Biologic Therapeutics Market Outlook, By Antibody Therapeutics (2021-2030) ($MN)
26 North America Biologic Therapeutics Market Outlook, By Other Products (2021-2030) ($MN)
27 North America Biologic Therapeutics Market Outlook, By Type (2021-2030) ($MN)
28 North America Biologic Therapeutics Market Outlook, By Allergenic Extracts (2021-2030) ($MN)
29 North America Biologic Therapeutics Market Outlook, By Blood Products (2021-2030) ($MN)
30 North America Biologic Therapeutics Market Outlook, By Human Cells and Tissues (2021-2030) ($MN)
31 North America Biologic Therapeutics Market Outlook, By Protein (2021-2030) ($MN)
32 North America Biologic Therapeutics Market Outlook, By Xenotransplantation Products (2021-2030) ($MN)
33 North America Biologic Therapeutics Market Outlook, By Other Types (2021-2030) ($MN)
34 North America Biologic Therapeutics Market Outlook, By Application (2021-2030) ($MN)
35 North America Biologic Therapeutics Market Outlook, By Autoimmune Diseases (2021-2030) ($MN)
36 North America Biologic Therapeutics Market Outlook, By Infectious Diseases (2021-2030) ($MN)
37 North America Biologic Therapeutics Market Outlook, By Cancer (2021-2030) ($MN)
38 North America Biologic Therapeutics Market Outlook, By Other Applications (2021-2030) ($MN)
39 Europe Biologic Therapeutics Market Outlook, By Country (2021-2030) ($MN)
40 Europe Biologic Therapeutics Market Outlook, By Product (2021-2030) ($MN)
41 Europe Biologic Therapeutics Market Outlook, By Gene Therapy (2021-2030) ($MN)
42 Europe Biologic Therapeutics Market Outlook, By Cell Therapy (2021-2030) ($MN)
43 Europe Biologic Therapeutics Market Outlook, By Vaccines (2021-2030) ($MN)
44 Europe Biologic Therapeutics Market Outlook, By Antibody Therapeutics (2021-2030) ($MN)
45 Europe Biologic Therapeutics Market Outlook, By Other Products (2021-2030) ($MN)
46 Europe Biologic Therapeutics Market Outlook, By Type (2021-2030) ($MN)
47 Europe Biologic Therapeutics Market Outlook, By Allergenic Extracts (2021-2030) ($MN)
48 Europe Biologic Therapeutics Market Outlook, By Blood Products (2021-2030) ($MN)
49 Europe Biologic Therapeutics Market Outlook, By Human Cells and Tissues (2021-2030) ($MN)
50 Europe Biologic Therapeutics Market Outlook, By Protein (2021-2030) ($MN)
51 Europe Biologic Therapeutics Market Outlook, By Xenotransplantation Products (2021-2030) ($MN)
52 Europe Biologic Therapeutics Market Outlook, By Other Types (2021-2030) ($MN)
53 Europe Biologic Therapeutics Market Outlook, By Application (2021-2030) ($MN)
54 Europe Biologic Therapeutics Market Outlook, By Autoimmune Diseases (2021-2030) ($MN)
55 Europe Biologic Therapeutics Market Outlook, By Infectious Diseases (2021-2030) ($MN)
56 Europe Biologic Therapeutics Market Outlook, By Cancer (2021-2030) ($MN)
57 Europe Biologic Therapeutics Market Outlook, By Other Applications (2021-2030) ($MN)
58 Asia Pacific Biologic Therapeutics Market Outlook, By Country (2021-2030) ($MN)
59 Asia Pacific Biologic Therapeutics Market Outlook, By Product (2021-2030) ($MN)
60 Asia Pacific Biologic Therapeutics Market Outlook, By Gene Therapy (2021-2030) ($MN)
61 Asia Pacific Biologic Therapeutics Market Outlook, By Cell Therapy (2021-2030) ($MN)
62 Asia Pacific Biologic Therapeutics Market Outlook, By Vaccines (2021-2030) ($MN)
63 Asia Pacific Biologic Therapeutics Market Outlook, By Antibody Therapeutics (2021-2030) ($MN)
64 Asia Pacific Biologic Therapeutics Market Outlook, By Other Products (2021-2030) ($MN)
65 Asia Pacific Biologic Therapeutics Market Outlook, By Type (2021-2030) ($MN)
66 Asia Pacific Biologic Therapeutics Market Outlook, By Allergenic Extracts (2021-2030) ($MN)
67 Asia Pacific Biologic Therapeutics Market Outlook, By Blood Products (2021-2030) ($MN)
68 Asia Pacific Biologic Therapeutics Market Outlook, By Human Cells and Tissues (2021-2030) ($MN)
69 Asia Pacific Biologic Therapeutics Market Outlook, By Protein (2021-2030) ($MN)
70 Asia Pacific Biologic Therapeutics Market Outlook, By Xenotransplantation Products (2021-2030) ($MN)
71 Asia Pacific Biologic Therapeutics Market Outlook, By Other Types (2021-2030) ($MN)
72 Asia Pacific Biologic Therapeutics Market Outlook, By Application (2021-2030) ($MN)
73 Asia Pacific Biologic Therapeutics Market Outlook, By Autoimmune Diseases (2021-2030) ($MN)
74 Asia Pacific Biologic Therapeutics Market Outlook, By Infectious Diseases (2021-2030) ($MN)
75 Asia Pacific Biologic Therapeutics Market Outlook, By Cancer (2021-2030) ($MN)
76 Asia Pacific Biologic Therapeutics Market Outlook, By Other Applications (2021-2030) ($MN)
77 South America Biologic Therapeutics Market Outlook, By Country (2021-2030) ($MN)
78 South America Biologic Therapeutics Market Outlook, By Product (2021-2030) ($MN)
79 South America Biologic Therapeutics Market Outlook, By Gene Therapy (2021-2030) ($MN)
80 South America Biologic Therapeutics Market Outlook, By Cell Therapy (2021-2030) ($MN)
81 South America Biologic Therapeutics Market Outlook, By Vaccines (2021-2030) ($MN)
82 South America Biologic Therapeutics Market Outlook, By Antibody Therapeutics (2021-2030) ($MN)
83 South America Biologic Therapeutics Market Outlook, By Other Products (2021-2030) ($MN)
84 South America Biologic Therapeutics Market Outlook, By Type (2021-2030) ($MN)
85 South America Biologic Therapeutics Market Outlook, By Allergenic Extracts (2021-2030) ($MN)
86 South America Biologic Therapeutics Market Outlook, By Blood Products (2021-2030) ($MN)
87 South America Biologic Therapeutics Market Outlook, By Human Cells and Tissues (2021-2030) ($MN)
88 South America Biologic Therapeutics Market Outlook, By Protein (2021-2030) ($MN)
89 South America Biologic Therapeutics Market Outlook, By Xenotransplantation Products (2021-2030) ($MN)
90 South America Biologic Therapeutics Market Outlook, By Other Types (2021-2030) ($MN)
91 South America Biologic Therapeutics Market Outlook, By Application (2021-2030) ($MN)
92 South America Biologic Therapeutics Market Outlook, By Autoimmune Diseases (2021-2030) ($MN)
93 South America Biologic Therapeutics Market Outlook, By Infectious Diseases (2021-2030) ($MN)
94 South America Biologic Therapeutics Market Outlook, By Cancer (2021-2030) ($MN)
95 South America Biologic Therapeutics Market Outlook, By Other Applications (2021-2030) ($MN)
96 Middle East & Africa Biologic Therapeutics Market Outlook, By Country (2021-2030) ($MN)
97 Middle East & Africa Biologic Therapeutics Market Outlook, By Product (2021-2030) ($MN)
98 Middle East & Africa Biologic Therapeutics Market Outlook, By Gene Therapy (2021-2030) ($MN)
99 Middle East & Africa Biologic Therapeutics Market Outlook, By Cell Therapy (2021-2030) ($MN)
100 Middle East & Africa Biologic Therapeutics Market Outlook, By Vaccines (2021-2030) ($MN)
101 Middle East & Africa Biologic Therapeutics Market Outlook, By Antibody Therapeutics (2021-2030) ($MN)
102 Middle East & Africa Biologic Therapeutics Market Outlook, By Other Products (2021-2030) ($MN)
103 Middle East & Africa Biologic Therapeutics Market Outlook, By Type (2021-2030) ($MN)
104 Middle East & Africa Biologic Therapeutics Market Outlook, By Allergenic Extracts (2021-2030) ($MN)
105 Middle East & Africa Biologic Therapeutics Market Outlook, By Blood Products (2021-2030) ($MN)
106 Middle East & Africa Biologic Therapeutics Market Outlook, By Human Cells and Tissues (2021-2030) ($MN)
107 Middle East & Africa Biologic Therapeutics Market Outlook, By Protein (2021-2030) ($MN)
108 Middle East & Africa Biologic Therapeutics Market Outlook, By Xenotransplantation Products (2021-2030) ($MN)
109 Middle East & Africa Biologic Therapeutics Market Outlook, By Other Types (2021-2030) ($MN)
110 Middle East & Africa Biologic Therapeutics Market Outlook, By Application (2021-2030) ($MN)
111 Middle East & Africa Biologic Therapeutics Market Outlook, By Autoimmune Diseases (2021-2030) ($MN)
112 Middle East & Africa Biologic Therapeutics Market Outlook, By Infectious Diseases (2021-2030) ($MN)
113 Middle East & Africa Biologic Therapeutics Market Outlook, By Cancer (2021-2030) ($MN)
114 Middle East & Africa Biologic Therapeutics Market Outlook, By Other Applications (2021-2030) ($MN)
List of Figures
List of Figures
Figure 1 Global Biologic Therapeutics Market Outlook (2021-2030) ($MN)
Figure 2 North America Biologic Therapeutics Market Outlook (2021-2030) ($MN)
Figure 3 US Biologic Therapeutics Market Outlook (2021-2030) ($MN)
Figure 4 Canada Biologic Therapeutics Market Outlook (2021-2030) ($MN)
Figure 5 Mexico Biologic Therapeutics Market Outlook (2021-2030) ($MN)
Figure 6 Europe Biologic Therapeutics Market Outlook (2021-2030) ($MN)
Figure 7 Germany Biologic Therapeutics Market Outlook (2021-2030) ($MN)
Figure 8 UK Biologic Therapeutics Market Outlook (2021-2030) ($MN)
Figure 9 Italy Biologic Therapeutics Market Outlook (2021-2030) ($MN)
Figure 10 France Biologic Therapeutics Market Outlook (2021-2030) ($MN)
Figure 11 Spain Biologic Therapeutics Market Outlook (2021-2030) ($MN)
Figure 12 Rest of Europe Biologic Therapeutics Market Outlook (2021-2030) ($MN)
Figure 13 Asia Pacific Biologic Therapeutics Market Outlook (2021-2030) ($MN)
Figure 14 Japan Biologic Therapeutics Market Outlook (2021-2030) ($MN)
Figure 15 China Biologic Therapeutics Market Outlook (2021-2030) ($MN)
Figure 16 India Biologic Therapeutics Market Outlook (2021-2030) ($MN)
Figure 17 Australia Biologic Therapeutics Market Outlook (2021-2030) ($MN)
Figure 18 New Zealand Biologic Therapeutics Market Outlook (2021-2030) ($MN)
Figure 19 South Korea Biologic Therapeutics Market Outlook (2021-2030) ($MN)
Figure 20 Rest of Asia Pacific Biologic Therapeutics Market Outlook (2021-2030) ($MN)
Figure 21 South America Biologic Therapeutics Market Outlook (2021-2030) ($MN)
Figure 22 Argentina Biologic Therapeutics Market Outlook (2021-2030) ($MN)
Figure 23 Brazil Biologic Therapeutics Market Outlook (2021-2030) ($MN)
Figure 24 Chile Biologic Therapeutics Market Outlook (2021-2030) ($MN)
Figure 25 Rest of South America Biologic Therapeutics Market Outlook (2021-2030) ($MN)
Figure 26 Middle East & Africa Biologic Therapeutics Market Outlook (2021-2030) ($MN)
Figure 27 Saudi Arabia Biologic Therapeutics Market Outlook (2021-2030) ($MN)
Figure 28 UAE Biologic Therapeutics Market Outlook (2021-2030) ($MN)
Figure 29 Qatar Biologic Therapeutics Market Outlook (2021-2030) ($MN)
Figure 30 South Africa Biologic Therapeutics Market Outlook (2021-2030) ($MN)
Figure 31 Rest of Middle East & Africa Biologic Therapeutics Market Outlook (2021-2030) ($MN)
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
